Thymus capitatus flavonoids inhibit infection of Kaposi's sarcoma-associated herpesvirus.
Autor: | Mekni-Toujani M; Laboratory of Epidemiology and Veterinary Microbiology, Institute Pasteur of Tunis, University of Tunis El Manar, Tunis-Belvedere, Tunisia., Mousavizadeh L; Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany., Gallo A; Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany., Ghram A; Laboratory of Epidemiology and Veterinary Microbiology, Institute Pasteur of Tunis, University of Tunis El Manar, Tunis-Belvedere, Tunisia. |
---|---|
Jazyk: | angličtina |
Zdroj: | FEBS open bio [FEBS Open Bio] 2022 Jun; Vol. 12 (6), pp. 1166-1177. Date of Electronic Publication: 2022 Apr 21. |
DOI: | 10.1002/2211-5463.13407 |
Abstrakt: | Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpes virus 8 (HHV-8), causes primary effusion lymphoma, multicentric Castleman's disease, and Kaposi's sarcoma. Few antiviral drugs are available to efficiently control KSHV infection, and therefore, the development of novel, effective anti-KSHV treatments is needed. The aim of this study was to determine the antiviral activity of ethanolic and aqueous extracts, essential oils, and certain flavonoids (hesperidin, eupafolin, and vicenin) derived from Thymus capitatus (commonly known as thyme). We assessed the toxicity of these different extracts and components in RPE-1 cell cultures using the MTS test and evaluated their antiviral effect using the TCID (© 2022 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.) |
Databáze: | MEDLINE |
Externí odkaz: |